<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34290090</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>30</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>FUS-ALS mutants alter FMRP phase separation equilibrium and impair protein translation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eabf8660</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.abf8660</ELocationID><Abstract><AbstractText>FUsed in Sarcoma (FUS) is a multifunctional RNA binding protein (RBP). FUS mutations lead to its cytoplasmic mislocalization and cause the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Here, we use mouse and human models with endogenous ALS-associated mutations to study the early consequences of increased cytoplasmic FUS. We show that in axons, mutant FUS condensates sequester and promote the phase separation of fragile X mental retardation protein (FMRP), another RBP associated with neurodegeneration. This leads to repression of translation in mouse and human FUS-ALS motor neurons and is corroborated in vitro, where FUS and FMRP copartition and repress translation. Last, we show that translation of FMRP-bound RNAs is reduced in vivo in FUS-ALS motor neurons. Our results unravel new pathomechanisms of FUS-ALS and identify a novel paradigm by which mutations in one RBP favor the formation of condensates sequestering other RBPs, affecting crucial biological functions, such as protein translation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Birsa</LastName><ForeName>Nicol</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8271-540X</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK. p.fratta@ucl.ac.uk n.birsa@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute, University College London, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ule</LastName><ForeName>Agnieszka M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-2775-3259</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garone</LastName><ForeName>Maria Giovanna</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0002-2101-4474</Identifier><AffiliationInfo><Affiliation>Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsang</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7615-5397</Identifier><AffiliationInfo><Affiliation>Program in Molecular Medicine, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattedi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0306-5796</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biophysics, CNR, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>P Andrew</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0003-4416-0631</Identifier><AffiliationInfo><Affiliation>Program in Molecular Medicine, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphrey</LastName><ForeName>Jack</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6274-6620</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarvis</LastName><ForeName>Seth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisiren</LastName><ForeName>Melis</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3416-8878</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Oscar G</ForeName><Initials>OG</Initials><Identifier Source="ORCID">0000-0002-3334-0568</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nosella</LastName><ForeName>Micheal L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Program in Molecular Medicine, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devoy</LastName><ForeName>Anny</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1293-0630</Identifier><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodo</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Fuente</LastName><ForeName>Rafaela Fernandez</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Elizabeth M C</ForeName><Initials>EMC</Initials><Identifier Source="ORCID">0000-0003-2850-9936</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9999-7223</Identifier><AffiliationInfo><Affiliation>Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viero</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-6755-285X</Identifier><AffiliationInfo><Affiliation>Institute of Biophysics, CNR, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forman-Kay</LastName><ForeName>Julie D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0001-8265-972X</Identifier><AffiliationInfo><Affiliation>Program in Molecular Medicine, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiavo</LastName><ForeName>Giampietro</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4319-8745</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute, University College London, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fratta</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8762-8188</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK. p.fratta@ucl.ac.uk n.birsa@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Centre for Neuromuscular Disease, Queen Square, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/M008606/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>PLAGNOL/OCT15/885-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R005184/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0801110</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FRATTA/JAN15/946-795</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S006508/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_EX_MR/N501931/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FISHER/APR14/874-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K018523/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>139135-51-6</RegistryNumber><NameOfSubstance UI="D051860">Fragile X Mental Retardation Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051860" MajorTopicYN="N">Fragile X Mental Retardation Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34290090</ArticleId><ArticleId IdType="pmc">PMC8294762</ArticleId><ArticleId IdType="doi">10.1126/sciadv.abf8660</ArticleId><ArticleId IdType="pii">7/30/eabf8660</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ederle H., Dormann D., TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 591, 1489&#x2013;1507 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Birsa N., Bentham M. P., Fratta P., Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Semin. Cell Dev. Biol. 99, 193&#x2013;201 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31132467</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M. E., Mackenzie I. R. A., Capell A., Schmid B., Neumann M., Haass C., ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 29, 2841&#x2013;2857 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Sendscheid O., El Oussini H., Jambeau M., Sun Y., Mersmann S., Wagner M., Dieterl&#xe9; S., Sinniger J., Dirrig-Grosch S., Drenner K., Birling M.-C., Qiu J., Zhou Y., Li H., Fu X.-D., Rouaux C., Shelkovnikova T., Witting A., Ludolph A. C., Kiefer F., Storkebaum E., Lagier-Tourenne C., Dupuis L., Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 35, 1077&#x2013;1097 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., Vos K. J. D., Nishimura A. L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K. L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P. N., Blair I. P., Nicholson G., de Belleroche J., Gallo J.-M., Miller C. C., Shaw C. E., Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208&#x2013;1211 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Kim H. J., Wang H., Monaghan J., Freyermuth F., Sung J. C., O&#x2019;Donovan K., Fare C. M., Diaz Z., Singh N., Zhang Z. C., Coughlin M., Sweeny E. A., DeSantis M. E., Jackrel M. E., Rodell C. B., Burdick J. A., King O. D., Gitler A. D., Lagier-Tourenne C., Pandey U. B., Chook Y. M., Taylor J. P., Shorter J., Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell 173, 677&#x2013;692.e20 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J. Q., Schierle G. S. K., Rees E., Miyashita A., Costa A. R., Dodd R. B., Chan F. T. S., Michel C. H., Kronenberg-Versteeg D., Li Y., Yang S.-P., Wakutani Y., Meadows W., Ferry R. R., Dong L., Tartaglia G. G., Favrin G., Lin W.-L., Dickson D. W., Zhen M., Ron D., Schmitt-Ulms G., Fraser P. E., Shneider N. A., Holt C., Vendruscolo M., Kaminski C. F., George-Hyslop P. S., ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron 88, 678&#x2013;690 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Niaki A. G., Sarkar J., Cai X., Rhine K., Vidaurre V., Guy B., Hurst M., Lee J. C., Koh H. R., Guo L., Fare C. M., Shorter J., Myong S., Loss of dynamic RNA interaction and aberrant phase separation induced by two distinct types of ALS/FTD-linked FUS mutations. Mol. Cell 77, 82&#x2013;94.e4 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6943187</ArticleId><ArticleId IdType="pubmed">31630970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M., Hutten S., Bourgeois B., Spreitzer E., Niedner-Boblenz A., Schifferer M., Ruepp M.-D., Simons M., Niessing D., Madl T., Dormann D., Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell 173, 706&#x2013;719.e13 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S., Wang G., Randle S. J., Ruggeri F. S., Varela J. A., Lin J. Q., Phillips E. C., Miyashita A., Williams D., Str&#xf6;hl F., Meadows W., Ferry R., Dardov V. J., Tartaglia G. G., Farrer L. A., Kaminski Schierle G. S., Kaminski C. F., Holt C. E., Fraser P. E., Schmitt-Ulms G., Klenerman D., Knowles T., Vendruscolo M., St George-Hyslop P., FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-&#x3c0; interactions. Cell 173, 720&#x2013;734.e15 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H. O., Jawerth L., Maharana S., Jahnel M., Hein M. Y., Stoynov S., Mahamid J., Saha S., Franzmann T. M., Pozniakovski A., Poser I., Maghelli N., Royer L. A., Weigert M., Myers E. W., Grill S., Drechsel D., Hyman A. A., Alberti S., A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162, 1066&#x2013;1077 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bampton A., Gittings L. M., Fratta P., Lashley T., Gatt A., The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis. Acta Neuropathol. 140, 599&#x2013;623 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547044</ArticleId><ArticleId IdType="pubmed">32748079</ArticleId></ArticleIdList></Reference><Reference><Citation>Devoy A., Kalmar B., Stewart M., Park H., Burke B., Noy S. J., Redhead Y., Humphrey J., Lo K., Jaeger J., Mejia Maza A., Sivakumar P., Bertolin C., Soraru G., Plagnol V., Greensmith L., Acevedo Arozena A., Isaacs A. M., Davies B., Fratta P., Fisher E. M. C., Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in &#x201c;FUSDelta14&#x201d; knockin mice. Brain 140, 2797&#x2013;2805 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5841203</ArticleId><ArticleId IdType="pubmed">29053787</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Kocerha J., Finch N., Crook R., Baker M., Desaro P., Johnston A., Rutherford N., Wojtas A., Kennelly K., Wszolek Z. K., Graff-Radford N., Boylan K., Rademakers R., De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum. Mutat. 31, E1377&#x2013;E1389 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922682</ArticleId><ArticleId IdType="pubmed">20232451</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A. M., Koppers M., Groen E. J. N., van den Heuvel D. M. A., Dini Modigliani S., Anink J. J., Fumoto K., van Diggelen F., Snelting A., Sodaar P., Verheijen B. M., Demmers J. A. A., Veldink J. H., Aronica E., Bozzoni I., den Hertog J., van den Berg L. H., Pasterkamp R. J., Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol. 132, 175&#x2013;196 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4947123</ArticleId><ArticleId IdType="pubmed">27164932</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen E. J. N., Fumoto K., Blokhuis A. M., Engelen-Lee J., Zhou Y., van den Heuvel D. M. A., Koppers M., van Diggelen F., van Heest J., Demmers J. A. A., Kirby J., Shaw P. J., Aronica E., Spliet W. G. M., Veldink J. H., van den Berg L. H., Pasterkamp R. J., ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum. Mol. Genet. 22, 3690&#x2013;3704 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23681068</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Ling S.-C., Qiu J., Albuquerque C. P., Zhou Y., Tokunaga S., Li H., Qiu H., Bui A., Yeo G. W., Huang E. J., Eggan K., Zhou H., Fu X.-D., Lagier-Tourenne C., Cleveland D. W., ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun. 6, 6171 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338613</ArticleId><ArticleId IdType="pubmed">25625564</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T., Chen S., Yu Y., Yan B., Haertlein T. C., Carrasco M. A., Tapia J. C., Zhai B., Das R., Lalancette-Hebert M., Sharma A., Chandran S., Sullivan G., Nishimura A. L., Shaw C. E., Gygi S. P., Shneider N. A., Maniatis T., Reed R., FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2, 799&#x2013;806 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3483417</ArticleId><ArticleId IdType="pubmed">23022481</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda K., Zhang H., Loiselle D., Haystead T., Macara I. G., Mili S., The RNA-binding protein Fus directs translation of localized mRNAs in APC-RNP granules. J. Cell Biol. 203, 737&#x2013;746 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857475</ArticleId><ArticleId IdType="pubmed">24297750</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q., Ge W., The tandem Agenet domain of fragile X mental retardation protein interacts with FUS. Sci. Rep. 7, 962 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5430443</ArticleId><ArticleId IdType="pubmed">28424484</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh J. N., Tosolini A. P., Gordon D., Devoy A., Fratta P., Fisher E. M. C., Talbot K., Schiavo G., Mice carrying ALS mutant TDP-43, but not mutant FUS, display in vivo defects in axonal transport of signaling endosomes. Cell Rep. 30, 3655&#x2013;3662.e2 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7090381</ArticleId><ArticleId IdType="pubmed">32187538</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan A. T., Kuryavyi V., Darnell J. C., Serganov A., Majumdar A., Ilin S., Raslin T., Polonskaia A., Chen C., Clain D., Darnell R. B., Patel D. J., Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction. Nat. Struct. Mol. Biol. 18, 796&#x2013;804 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3130835</ArticleId><ArticleId IdType="pubmed">21642970</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang B., Arsenault J., Vernon R. M., Lin H., Sonenberg N., Wang L.-Y., Bah A., Forman-Kay J. D., Phosphoregulated FMRP phase separation models activity-dependent translation through bidirectional control of mRNA granule formation. Proc. Natl. Acad. Sci. U.S.A. 116, 4218&#x2013;4227 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6410804</ArticleId><ArticleId IdType="pubmed">30765518</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T. H., Tsang B., Vernon R. M., Sonenberg N., Kay L. E., Forman-Kay J. D., Phospho-dependent phase separation of FMRP and CAPRIN1 recapitulates regulation of translation and deadenylation. Science 365, 825&#x2013;829 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31439799</ArticleId></ArticleIdList></Reference><Reference><Citation>Krichevsky A. M., Kosik K. S., Neuronal RNA granules: A link between RNA localization and stimulation-dependent translation. Neuron 32, 683&#x2013;696 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11719208</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo P. K., Lee S. J., Jaiswal P. B., Alber S., Kar A. N., Miller-Randolph S., Taylor E. E., Smith T., Singh B., Ho T. S.-Y., Urisman A., Chand S., Pena E. A., Burlingame A. L., Woolf C. J., Fainzilber M., English A. W., Twiss J. L., Axonal G3BP1 stress granule protein limits axonal mRNA translation and nerve regeneration. Nat. Commun. 9, 3358 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105716</ArticleId><ArticleId IdType="pubmed">30135423</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J., Tadokoro T., Baughn M. W., Myers B., McAlonis-Downes M., Chillon-Marinas C., Asiaban J. N., Artates J., Bui A. T., Vetto A. P., Lee S. K., Le A. V., Sun Y., Jambeau M., Boubaker J., Swing D., Qiu J., Hicks G. G., Ouyang Z., Fu X.-D., Tessarollo L., Ling S.-C., Parone P. A., Shaw C. E., Marsala M., Lagier-Tourenne C., Cleveland D. W., Da Cruz S., ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron 100, 816&#x2013;830.e7 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Simsek D., Tiu G. C., Flynn R. A., Byeon G. W., Leppek K., Xu A. F., Chang H. Y., Barna M., The mammalian ribo-interactome reveals ribosome functional diversity and heterogeneity. Cell 169, 1051&#x2013;1065.e18 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5548193</ArticleId><ArticleId IdType="pubmed">28575669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernab&#xf2; P., Tebaldi T., Groen E. J. N., Lane F. M., Perenthaler E., Mattedi F., Newbery H. J., Zhou H., Zuccotti P., Potrich V., Shorrock H. K., Muntoni F., Quattrone A., Gillingwater T. H., Viero G., In vivo translatome profiling in spinal muscular atrophy reveals a role for SMN protein in ribosome biology. Cell Rep. 21, 953&#x2013;965 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5668566</ArticleId><ArticleId IdType="pubmed">29069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell J. C., Van Driesche S. J., Zhang C., Hung K. Y. S., Mele A., Fraser C. E., Stone E. F., Chen C., Fak J. J., Chi S. W., Licatalosi D. D., Richter J. D., Darnell R. B., FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247&#x2013;261 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3232425</ArticleId><ArticleId IdType="pubmed">21784246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz E., Yang L., Su T., Morris D. R., McKnight G. S., Amieux P. S., Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc. Natl. Acad. Sci. U.S.A. 106, 13939&#x2013;13944 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2728999</ArticleId><ArticleId IdType="pubmed">19666516</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogelj B., Easton L. E., Bogu G. K., Stanton L. W., Rot G., Curk T., Zupan B., Sugimoto Y., Modic M., Haberman N., Tollervey J., Fujii R., Takumi T., Shaw C. E., Ule J., Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2, 603 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3429604</ArticleId><ArticleId IdType="pubmed">22934129</ArticleId></ArticleIdList></Reference><Reference><Citation>Goering R., Hudish L. I., Guzman B. B., Raj N., Bassell G. J., Russ H. A., Dominguez D., Taliaferro J. M., FMRP promotes RNA localization to neuronal projections through interactions between its RGG domain and G-quadruplex RNA sequences. eLife 9, e52621 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279889</ArticleId><ArticleId IdType="pubmed">32510328</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson S. R., Seo S. S., Barnes S. A., Louros S. R., Muscas M., Dando O., Kirby C., Wyllie D. J. A., Hardingham G. E., Kind P. C., Osterweil E. K., Cell-type-specific translation profiling reveals a novel strategy for treating fragile X syndrome. Neuron 95, 550&#x2013;563.e5 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5548955</ArticleId><ArticleId IdType="pubmed">28772121</ArticleId></ArticleIdList></Reference><Reference><Citation>Garone M. G., Alfano V., Salvatori B., Braccia C., Peruzzi G., Colantoni A., Bozzoni I., Armirotti A., Rosa A., Proteomics analysis of FUS mutant human motoneurons reveals altered regulation of cytoskeleton and other ALS-linked proteins via 3&#x2032; UTR binding. Sci. Rep. 10, 11827 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366621</ArticleId><ArticleId IdType="pubmed">32678235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylikallio E., P&#xf6;yh&#xf6;nen R., Zimon M., De Vriendt E., Hilander T., Paetau A., Jordanova A., L&#xf6;nnqvist T., Tyynismaa H., Deficiency of the E3 ubiquitin ligase TRIM2 in early-onset axonal neuropathy. Hum. Mol. Genet. 22, 2975&#x2013;2983 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23562820</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M., Chen J., Kuang L., Jin H., Kasarskis E. J., Zhu H., ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc. Natl. Acad. Sci. U.S.A. 115, E11904&#x2013;E11913 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6304956</ArticleId><ArticleId IdType="pubmed">30455313</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe9;vigny M., Bourdeau Julien I., Venkatasubramani J. P., Hui J. B., Dutchak P. A., Sephton C. F., FUS contributes to mTOR-dependent inhibition of translation. J. Biol. Chem. 295, 18459&#x2013;18473 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7939483</ArticleId><ArticleId IdType="pubmed">33082139</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J. C., McGoldrick P., Vance C., Hortobagyi T., Sreedharan J., Rogelj B., Tudor E. L., Smith B. N., Klasen C., Miller C. C. J., Cooper J. D., Greensmith L., Shaw C. E., Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 125, 273&#x2013;288 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H., Lee S., Shang Y., Wang W.-Y., Au K. F., Kamiya S., Barmada S. J., Finkbeiner S., Lui H., Carlton C. E., Tang A. A., Oldham M. C., Wang H., Shorter J., Filiano A. J., Roberson E. D., Tourtellotte W. G., Chen B., Tsai L.-H., Huang E. J., ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Invest. 124, 981&#x2013;999 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C. F., Tang A. A., Kulkarni A., West J., Brooks M., Stubblefield J. J., Liu Y., Zhang M. Q., Green C. B., Huber K. M., Huang E. J., Herz J., Yu G., Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc. Natl. Acad. Sci. U.S.A. 111, E4769&#x2013;E4778 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4226112</ArticleId><ArticleId IdType="pubmed">25324524</ArticleId></ArticleIdList></Reference><Reference><Citation>Cid-Samper F., Gelabert-Baldrich M., Lang B., Lorenzo-Gotor N., Ponti R. D., Severijnen L.-A. W. F. M., Bolognesi B., Gelpi E., Hukema R. K., Botta-Orfila T., Tartaglia G. G., An integrative study of protein-RNA condensates identifies scaffolding rnas and reveals players in fragile X-associated tremor/ataxia syndrome. Cell Rep. 25, 3422&#x2013;3434.e7 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6315285</ArticleId><ArticleId IdType="pubmed">30566867</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter J. D., Bassell G. J., Klann E., Dysregulation and restoration of translational homeostasis in fragile X syndrome. Nat. Rev. Neurosci. 16, 595&#x2013;605 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4688896</ArticleId><ArticleId IdType="pubmed">26350240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Sgobio C., Arzberger T., Machleid F., Tang Q., Findeis E., Tost J., Chakroun T., Gao P., H&#xf6;llerhage M., B&#xf6;tzel K., Herms J., H&#xf6;glinger G., Koeglsperger T., Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson&#x2019;s disease. Acta Neuropathol. 139, 319&#x2013;345 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31768670</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd P. K., Oh S. Y., Krans A., He F., Sellier C., Frazer M., Renoux A. J., Chen K., Scaglione K. M., Basrur V., Elenitoba-Johnson K., Vonsattel J. P., Louis E. D., Sutton M. A., Taylor J. P., Mills R. E., Charlet-Berguerand N., Paulson H. L., CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 78, 440&#x2013;455 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3831531</ArticleId><ArticleId IdType="pubmed">23602499</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum A. R., Wu B., Singer R. H., Single &#x3b2;-actin mRNA detection in neurons reveals a mechanism for regulating its translatability. Science 343, 419&#x2013;422 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4121734</ArticleId><ArticleId IdType="pubmed">24458642</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H. Y., Lim H., Yoon Y. J., Follenzi A., Nwokafor C., Lopez-Jones M., Meng X., Singer R. H., Visualization of dynamics of single endogenous mRNA labeled in live mouse. Science 343, 422&#x2013;424 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4111226</ArticleId><ArticleId IdType="pubmed">24458643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Choi J.-M., Holehouse A. S., Lee H. O., Zhang X., Jahnel M., Maharana S., Lemaitre R., Pozniakovsky A., Drechsel D., Poser I., Pappu R. V., Alberti S., Hyman A. A., A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell 174, 688&#x2013;699.e16 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063760</ArticleId><ArticleId IdType="pubmed">29961577</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A. M., Groen E. J. N., Koppers M., van den Berg L. H., Pasterkamp R. J., Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 125, 777&#x2013;794 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonatopoulos-Pournatzis T., Niibori R., Salter E. W., Weatheritt R. J., Tsang B., Farhangmehr S., Liang X., Braunschweig U., Roth J., Zhang S., Henderson T., Sharma E., Quesnel-Valli&#xe8;res M., Permanyer J., Maier S., Georgiou J., Irimia M., Sonenberg N., Forman-Kay J. D., Gingras A.-C., Collingridge G. L., Woodin M. A., Cordes S. P., Blencowe B. J., Autism-misregulated eIF4G microexons control synaptic translation and higher order cognitive functions. Mol. Cell 77, 1176&#x2013;1192.e16 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31999954</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J., Birsa N., Milioto C., McLaughlin M., Ule A. M., Robaldo D., Eberle A. B., Kr&#xe4;uchi R., Bentham M., Brown A.-L., Jarvis S., Bodo C., Garone M. G., Devoy A., Soraru G., Rosa A., Bozzoni I., Fisher E. M. C., M&#xfc;hlemann O., Schiavo G., Ruepp M.-D., Isaacs A. M., Plagnol V., Fratta P., FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res. 48, 6889&#x2013;6905 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>Garone M. G., Birsa N., Rosito M., Salaris F., Mochi M., de Turris V., Nair R. R., Cunningham T. J., Fisher E. M. C., Fratta P., Rosa A., RNA-binding protein network alteration causes aberrant axon branching and growth phenotypes in FUS ALS mutant motoneurons. bioRxiv, 2020.08.26.268631 , (2020).</Citation></Reference><Reference><Citation>Tyzack G. E., Luisier R., Taha D. M., Neeves J., Modic M., Mitchell J. S., Meyer I., Greensmith L., Newcombe J., Ule J., Luscombe N. M., Patani R., Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain 142, 2572&#x2013;2580 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashley T., Rohrer J. D., Bandopadhyay R., Fry C., Ahmed Z., Isaacs A. M., Brelstaff J. H., Borroni B., Warren J. D., Troakes C., King A., Al-Saraj S., Newcombe J., Quinn N., Ostergaard K., Schr&#xf8;der H. D., Bojsen-M&#xf8;ller M., Braendgaard H., Fox N. C., Rossor M. N., Lees A. J., Holton J. L., Revesz T., A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain 134, 2548&#x2013;2564 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170529</ArticleId><ArticleId IdType="pubmed">21752791</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H. A., Mackenzie I. R. A., A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922&#x2013;2931 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu S., Liu G., &#xd6;zt&#xfc;rk A., Hicks G. G., ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLOS Genet. 9, e1003895 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C., Bassell G. J., Rossoll W., High-efficiency transfection of cultured primary motor neurons to study protein localization, trafficking, and function. Mol. Neurodegener. 5, 17 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2867961</ArticleId><ArticleId IdType="pubmed">20406490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi J., De Santis R., de Turris V., Morlando M., Laneve P., Calvo A., Caliendo V., Chi&#xf2; A., Rosa A., Bozzoni I., ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons. Dis. Model. Mech. 8, 755&#x2013;766 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486861</ArticleId><ArticleId IdType="pubmed">26035390</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R., Alfano V., de Turris V., Colantoni A., Santini L., Garone M. G., Antonacci G., Peruzzi G., Sudria-Lopez E., Wyler E., Anink J. J., Aronica E., Landthaler M., Pasterkamp R. J., Bozzoni I., Rosa A., Mutant FUS and ELAVL4 (HuD) aberrant crosstalk in amyotrophic lateral sclerosis. Cell Rep. 27, 3818&#x2013;3831.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613039</ArticleId><ArticleId IdType="pubmed">31242416</ArticleId></ArticleIdList></Reference><Reference><Citation>Restani L., Giribaldi F., Manich M., Bercsenyi K., Menendez G., Rossetto O., Caleo M., Schiavo G., Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLOS Pathog. 8, e1003087 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3531519</ArticleId><ArticleId IdType="pubmed">23300443</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T. G., Niccoli T., Wilson K. M., Atilano M. L., Birsa N., Gittings L. M., Holbling B. V., Dyson M. C., Thoeng A., Neeves J., Glaria I., Yu L., Bussmann J., Storkebaum E., Pardo M., Choudhary J. S., Fratta P., Partridge L., Isaacs A. M., C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 137, 487&#x2013;500 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514073</ArticleId><ArticleId IdType="pubmed">30604225</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielson E., Lee S. H., SynPAnal: Software for rapid quantification of the density and intensity of protein puncta from fluorescence microscopy images of neurons. PLOS ONE 9, e115298 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4274056</ArticleId><ArticleId IdType="pubmed">25531531</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellows A. D., Rhymes E. R., Gibbs K. L., Greensmith L., Schiavo G., IGF1R regulates retrograde axonal transport of signalling endosomes in motor neurons. EMBO Rep. 21, e49129 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054680</ArticleId><ArticleId IdType="pubmed">32030864</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinevez J.-Y., Perry N., Schindelin J., Hoopes G. M., Reynolds G. D., Laplantine E., Bednarek S. Y., Shorte S. L., Eliceiri K. W., TrackMate: An open and extensible platform for single-particle tracking. Methods 115, 80&#x2013;90 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27713081</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigeoka T., Jung H., Jung J., Turner-Bridger B., Ohk J., Lin J. Q., Amieux P. S., Holt C. E., Dynamic axonal translation in developing and mature visual circuits. Cell 166, 181&#x2013;192 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4930487</ArticleId><ArticleId IdType="pubmed">27321671</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A., Davis C. A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T. R., STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15&#x2013;21 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudge J. M., Harrow J., Creating reference gene annotation for the mouse C57BL6/J genome assembly. Mamm. Genome 26, 366&#x2013;378 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4602055</ArticleId><ArticleId IdType="pubmed">26187010</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M. I., Huber W., Anders S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimand J., Kull M., Peterson H., Hansen J., Vilo J., g:Profiler&#x2014;A web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 35, W193&#x2013;W200 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1933153</ArticleId><ArticleId IdType="pubmed">17478515</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcante R. G., Sartor M. A., annotatr: Genomic regions in context. Bioinformatics 33, 2381&#x2013;2383 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5860117</ArticleId><ArticleId IdType="pubmed">28369316</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson, org.Mm.eg.db: Genome wide annotation for Mouse. R package version 3.8.2. (2019).</Citation></Reference><Reference><Citation>Carlson, Maintainer, TxDb.Mmusculus.UCSC.mm9.knownGene: Annotation package for TxDb object(s). R package version 3.2.2. (2015), doi:10.18129/B9.bioc.TxDb.Mmusculus.UCSC.mm9.knownGene.</Citation><ArticleIdList><ArticleId IdType="doi">10.18129/B9.bioc.TxDb.Mmusculus.UCSC.mm9.knownGene</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G., Wang L.-G., Han Y., He Q.-Y., clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284&#x2013;287 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>